✦ LIBER ✦

Abstract No. 141: Phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: Interim safety analysis

✍ Scribed by Reyes, D.; Azad, N.; Koteish, A.; Kamel, I.; Hamilton, J.; Georgiades, C.; Pawlik, T.; Choti, M.; Geschwind, J.H.

Book ID: 122040515
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 151 KB
Volume: 21
Category: Article
ISSN: 1051-0443
DOI: 10.1016/j.jvir.2009.12.296

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abstract No. 4: Phase II trial of sorafe

Abstract No. 4: Phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: Interim efficacy analysis

✍ Reyes, D.; Azad, N.; Koteish, A.; Kamel, I.; Hamilton, J.; Pawlik, T.; Choti, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Prospective phase II trial of sorafenib

Prospective phase II trial of sorafenib combined with doxorubicin eluting bead-transarterial chemoembolization for patients with unresectable hepatocellular carcinoma: efficacy analysis

✍ Feng, A.; Reyes, D.; Kamel, I.; Gowdra Halappa, V.; Corona Villalobos, C.; Cosgr 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Phase II Trial of Sorafenib Combined Wit

Phase II Trial of Sorafenib Combined With Concurrent Transarterial Chemoembolization With Drug-Eluting Beads for Hepatocellular Carcinoma

✍ Pawlik, T. M.; Reyes, D. K.; Cosgrove, D.; Kamel, I. R.; Bhagat, N.; Geschwind, 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 181 KB

Abstract No. 142: Single centre phase II

Abstract No. 142: Single centre phase II trial of transarterial chemoembolization with drug eluting beads for patients with unresectable hepatocellular carcinoma: Initial experience in the USA

✍ Reyes, D.; Vossen, J.A.; Kamel, I.; Azad, N.; Wahlin, T.; Torbenson, M.; Choti, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Abstract No. 135: A randomized phase II

Abstract No. 135: A randomized phase II study of transarterial chemoembolization with doxorubicin eluting super absorbent polymer microspheres in patients with unresectable hepatocellular carcinoma

✍ Maleux, G.; van Malenstein, H.; Heye, S.; Vandecaveye, V.; Laleman, W.; Nevens, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Abstract No. 140: Phase II trial of beva

Abstract No. 140: Phase II trial of bevacizumab combined with transarterial chemoembolization (TACE) for hepatocellular carcinoma: Initial experience at two institutions

✍ Reyes, D.; Vossen, J.A.; Kamel, I.; Mulcahy, M.F.; Salem, R.; Messersmith, W.; W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 128 KB